Affinity Asset Advisors »

Praxis Precision Medicines I shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Praxis Precision Medicines I (PRAX) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Praxis Precision Medicines I

Tip: Access up to 7 years of quarterly data

All positions including Praxis Precision Medicines I held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Praxis Precision Medicines I by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $55M 185k 294.74

More positions owned by Affinity Asset Advisors

Spdr Series Trust State Street Spd Put Option (XBI)
Apogee Therapeutics (APGE)
Insmed Com Par $.01 (INSM)
Abivax Sa Sponsored Ads (ABVX)
Ishares Tr Ishares Biotech Call Option (IBB)
Ventyx Biosciences (VTYX)
Xenon Pharmaceuticals (XENE)
Praxis Precision Medicines I Com New (PRAX)
Cytokinetics Com New (CYTK)
Amgen (AMGN)
Spyre Therapeutics Com New (SYRE)
Wave Life Sciences SHS (WVE)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Select Sector Spdr Tr State Street Hea Call Option (XLV)
Roivant Sciences SHS (ROIV)

View all positions for Affinity Asset Advisors

Top funds holding Praxis Precision Medicines I

Henderson Group
Adage Capital Partners GP
BlackRock
Perceptive Advisors
Vanguard Group
Orbis Allan Gray
Point72 Asset Management
Cormorant Asset Management
Deerfield Management Company
State Street Corporation
Goldman Sachs Group
Baker Bros. Advisors
Geode Capital Management
Barclays
Driehaus Capital Management

View all funds holding Praxis Precision Medicines I